Your browser doesn't support javascript.
loading
Effect of maraviroc on non-R5 tropic HIV-1: refined analysis of subjects from the phase IIb study A4001029.
Surdo, M; Alteri, C; Puertas, M C; Saccomandi, P; Parrotta, L; Swenson, L; Chapman, D; Costa, G; Artese, A; Balestra, E; Aquaro, S; Alcaro, S; Lewis, M; Clotet, B; Harrigan, R; Valdez, H; Svicher, V; Perno, C F; Martinez-Picado, J; Ceccherini-Silberstein, F.
Afiliação
  • Surdo M; Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy.
  • Alteri C; Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy.
  • Puertas MC; Institut de Recerca de la SIDA irsiCaixa, Hospital Universitari 'Germans Trias i Pujol', Badalona, Universitat Autònoma de Barcelona (UAB), Catalonia, Spain.
  • Saccomandi P; Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy.
  • Parrotta L; Department of Pharmacobiological Sciences, University of Catanzaro 'Magna Græcia', Catanzaro, Italy.
  • Swenson L; BC Centre for Excellence in HIV/AIDS, Vancouver, Canada.
  • Chapman D; Pfizer, New York, NY, USA.
  • Costa G; Department of Pharmacobiological Sciences, University of Catanzaro 'Magna Græcia', Catanzaro, Italy.
  • Artese A; Department of Pharmacobiological Sciences, University of Catanzaro 'Magna Græcia', Catanzaro, Italy.
  • Balestra E; Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy.
  • Aquaro S; Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Rende, Italy.
  • Alcaro S; Department of Pharmacobiological Sciences, University of Catanzaro 'Magna Græcia', Catanzaro, Italy.
  • Lewis M; Pfizer, UK.
  • Clotet B; Institut de Recerca de la SIDA irsiCaixa, Hospital Universitari 'Germans Trias i Pujol', Badalona, Universitat Autònoma de Barcelona (UAB), Catalonia, Spain; Universitat de Vic (UVic), Catalonia, Spain.
  • Harrigan R; BC Centre for Excellence in HIV/AIDS, Vancouver, Canada.
  • Valdez H; Pfizer, New York, NY, USA.
  • Svicher V; Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy.
  • Perno CF; Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy.
  • Martinez-Picado J; Institut de Recerca de la SIDA irsiCaixa, Hospital Universitari 'Germans Trias i Pujol', Badalona, Universitat Autònoma de Barcelona (UAB), Catalonia, Spain; Universitat de Vic (UVic), Catalonia, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.
  • Ceccherini-Silberstein F; Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy. Electronic address: ceccherini@med.uniroma2.it.
Clin Microbiol Infect ; 21(1): 103.e1-6, 2015 Jan.
Article em En | MEDLINE | ID: mdl-25636934
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Triazóis / Infecções por HIV / HIV-1 / Cicloexanos / Antagonistas dos Receptores CCR5 Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Clin Microbiol Infect Assunto da revista: DOENCAS TRANSMISSIVEIS / MICROBIOLOGIA Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Itália
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Triazóis / Infecções por HIV / HIV-1 / Cicloexanos / Antagonistas dos Receptores CCR5 Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Clin Microbiol Infect Assunto da revista: DOENCAS TRANSMISSIVEIS / MICROBIOLOGIA Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Itália